Awridian has a proven track record with a range of groups across Drug Discovery, these include start-ups, small bio-techs, pharmaceutical companies, and academics.

Areas of expertise are illustrated by publications and presentations which include topics such as new modalities, open innovation in drug discovery, the evolving landscape of charity sector’s engagement with drug discovery along with screening compound, fragments and building block design and acquisition.

Awridian can move your project forward by identifying a supplier of the required service for example chemistry (arrays, test compound, fragments, or intermediates) or biological assays (in vitro, in vivo and DMPK). Furthermore, Awridian recognises that acquiring the appropriate compounds either for hit identification projects, or for larger projects such as refreshing your screening collection is critical.  In addition Awridian can advise on the tractability of Medicinal Chemistry Projects and how to enhance your chance of success.

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.